Safety of trivalent Adjuvanted influenza vaccine (aIIV3; Fluad), vaccine adverse event reporting system (VAERS), United States, July 2016-June 2018

被引:0
|
作者
Haber, Penina [1 ]
Moro, Pedro [1 ]
Ng, Carmen [1 ]
Dores, Graca M. [2 ]
Page, Lewis [1 ]
Cano, Maria [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] US FDA, Rockville, MD 20857 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
810
引用
收藏
页码:392 / 393
页数:2
相关论文
共 50 条
  • [1] Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018
    Haber, Penina
    Moro, Pedro L.
    Ng, Carmen
    Dores, Graca M.
    Lewis, Paige
    Cano, Maria
    [J]. VACCINE, 2019, 37 (11) : 1516 - 1520
  • [2] Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013
    Haber, Penina
    Moro, Pedro L.
    McNeil, Michael M.
    Lewis, Paige
    Woo, Emily Jane
    Hughes, Hayley
    Shimabukuro, Tom T.
    [J]. VACCINE, 2014, 32 (48) : 6499 - 6504
  • [3] Monitoring the safety of high-dose, trivalent influenza vaccine in the vaccine adverse event reporting system (VAERS), 2010-2018
    Moro, Pedro
    Lewis, Paige
    Cano, Maria
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 388 - 389
  • [4] Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, vaccine adverse event reporting system (VAERS), July 2013-June 2014
    Haber, Penina
    Moro, Pedro L.
    Cano, Maria
    Lewis, Paige
    Stweart, Brock
    Shimabukuro, Tom T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 180 - 180
  • [5] Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014
    Haber, Penina
    Moro, Pedro L.
    Cano, Maria
    Lewis, Paige
    Stewart, Brock
    Shimabukuro, Tom T.
    [J]. VACCINE, 2015, 33 (16) : 1987 - 1992
  • [6] Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
    Shimabukuro, Tom T.
    Nguyen, Michael
    Martin, David
    DeStefano, Frank
    [J]. VACCINE, 2015, 33 (36) : 4398 - 4405
  • [7] The role of the vaccine adverse event reporting system (VAERS) in monitoring vaccine safety
    Iskander, JK
    Miller, ER
    Chen, RT
    [J]. PEDIATRIC ANNALS, 2004, 33 (09): : 599 - 606
  • [8] Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011-2019
    Moro, Pedro L.
    Woo, Emily Jane
    Marquez, Paige
    Cano, Maria
    [J]. VACCINE, 2020, 38 (37) : 5923 - 5926
  • [9] Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
    Woo, Emily Jane
    Moro, Pedro L.
    Cano, Maria
    Jankosky, Christopher
    [J]. VACCINE, 2017, 35 (42) : 5618 - 5621
  • [10] Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011-July 2018
    McNeil, Michael M.
    Paradowska-Stankiewicz, Iwona
    Miller, Elaine R.
    Marquez, Paige L.
    Seshadri, Srihari
    Collins, Limone C., Jr.
    Cano, Maria, V
    [J]. VACCINE, 2019, 37 (44) : 6760 - 6767